ArticleHaematologica2017
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide.
Open access · goldAbstract readMulticenter Study
In one paragraph
Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 35 citations in OpenAlex.
- Trial
- Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation.Scientific reports · 2021Trial
- The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.Bone marrow transplantation · 2019Trial
- Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation.British journal of haematology · 2026Article
- Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years.Blood advances · 2026Article
- Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering Committee.Cytotherapy · 2025Review
- Soluble ST2 as a Predictive Biomarker for Acute Graft-Versus-Host Disease Post -Allogeneic Stem Cell Transplantation.Clinical transplantation · 2025Article
- Application of CD25 and CTLA4 gene transcription levels in early prediction of acute graft-versus-host disease.Frontiers in immunology · 2024Article
- EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.Bone marrow transplantation · 2023Article
- Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges.Frontiers in immunology · 2023Review
- Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.Transplantation and cellular therapy · 2022Review
- General Rehabilitation Program after Knee or Hip Replacement Significantly Influences Erythrocytes Oxidative Stress Markers and Serum ST2 Levels.Oxidative medicine and cellular longevity · 2022Article
- Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.British journal of haematology · 2021Review
- Elafin as a Predictive Biomarker of Acute Skin Graft-Frontiers in immunology · 2021Article
- Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.Blood · 2020Article
- High prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamide.Bone marrow transplantation · 2020Article
- Biomarkers for Allogeneic HCT Outcomes.Frontiers in immunology · 2020Review
- Multiple functional variants in theBlood advances · 2019Article
- A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value.JCI insight · 2019Article
- ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells.Journal of immunology (Baltimore, Md. : 1950) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 5 institutions in 1 country.
Christopher G KanakrySidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Giorgos BakoyannisDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN.
Susan M PerkinsDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN.
Shannon R McCurdySidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Ante VulicSidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Edus H WarrenClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Etienne DaguindauDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Taylor OlmstedDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Christen MumawDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Andrea M H TowlertonClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Kenneth R CookeSidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Paul V O'DonnellClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Heather J SymonsSidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
Sophie PaczesnyDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN luznile@jhmi.edu sophpacz@iu.edu.
Leo LuznikSidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD luznile@jhmi.edu sophpacz@iu.edu.
Indiana University School of MedicineJohns Hopkins University · USFred Hutch Cancer Center · USIndiana University – Purdue University Indianapolis · USSidney Kimmel Comprehensive Cancer Center · US
Funding
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host DiseaseR01CA168814 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PACZESNY, SOPHIE · 2013 to 2024
$3.0MMECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDER01HL110907 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI LUZNIK, LEO, WARREN, EDUS HOUSTON · 2012 to 2015
$1.7MNCI NIH HHS R01 CA168814NHLBI NIH HHS R01 HL110907
Abstract
Recent studies have suggested that plasma-derived proteins may be potential biomarkers relevant for graft-
Indexed as
AdultAgedAntineoplastic Agents, AlkylatingBiomarkersBone Marrow TransplantationCyclophosphamideFemaleGraft vs Host DiseaseHematologic NeoplasmsHistocompatibility TestingHLA AntigensHumansInterleukin-1 Receptor-Like 1 ProteinInterleukin-2 Receptor alpha SubunitMaleMiddle AgedAntineoplastic Agents, AlkylatingBiomarkersCyclophosphamideHLA AntigensIL1RL1 protein, humanInterleukin-1 Receptor-Like 1 ProteinInterleukin-2 Receptor alpha SubunitPancreatitis-Associated ProteinsReceptors, Tumor Necrosis Factor, Type IREG3A protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.